You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

signaling pathway

Showing 1 - 25 of 4,414
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Prediabetes Trial in La Jolla (Mirabegron)

Not yet recruiting
  • Obesity, Prediabetes
  • La Jolla, California
    UC San Diego Altman Clinical & Translational Research Institute
Nov 21, 2022

JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

Not yet recruiting
  • Pyoderma Gangrenosum
  • +2 more
  • immunohistochemical methods
  • (no location specified)
Mar 21, 2022

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Biospecimen Collection, Follow-Up)

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Biospecimen Collection
  • Follow-Up
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

VEGF-B Signaling Pathway in Obesity and Metabolic Disease

Completed
  • Obesity
  • Metabolic Disease
    • Wuhan, Hubei, China
      Department of Endocrinology, Union Hospital,Tongji Medical Colle
    Apr 5, 2021

    Esophageal Cancer Trial in Dallas (Itraconazole)

    Active, not recruiting
    • Esophageal Cancer
    • Dallas, Texas
      Dallas VA Medical Center
    Nov 2, 2021

    Chronic Lymphocytic Leukemia Trial in United States (ABT-199)

    Completed
    • Chronic Lymphocytic Leukemia
    • La Jolla, California
    • +14 more
    Dec 29, 2021

    Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Breast Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 16, 2022

    Macrophages, GM-CSF and MARS Proteinosis

    Recruiting
    • Pulmonary Alveolar Proteinosis (PAP)
    • +2 more
    • Blood collection
    • Bronchoalveolar lavage fluid collection
    • Paris, France
      Hôpital Necker-Enfants Malades
    Jun 26, 2021

    Solid Tumor, Adult, Hepatocellular Carcinoma Trial in Guangzhou (Combination of three inhibitors Trametinib, Everolimus and

    Recruiting
    • Solid Tumor, Adult
    • Hepatocellular Carcinoma
    • Combination of three inhibitors Trametinib, Everolimus and Lenvatinib
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Apr 7, 2021

    New Signaling Pathway Targeting Systemic Lupus Erythematosus

    Unknown status
    • SLE
    • Taking peripheral blood samples
    • (no location specified)
    Jun 27, 2019

    JAK/STAT Pathway in Sarcoidosis Granuloma Cells

    Recruiting
    • Sarcoidosis
    • JAK-STAT Pathway Deregulation
    • Blood sample
    • Bobigny, France
      Service de pneumologie Hôpital Avicenne
    Oct 3, 2022

    CNS Lymphoma Trial in Beijing (Zanubrutinib)

    Recruiting
    • CNS Lymphoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Aug 1, 2022

    Preterm Birth, Mother-Infant Interaction, Infant Development Trial in Cologne (skin-to-skin contact)

    Recruiting
    • Preterm Birth
    • +2 more
    • skin-to-skin contact
    • Cologne, Northrhine-westfalia, Germany
      University hospital of Cologne, Department of Neonatology
    Aug 4, 2023

    H. Pylori Infection, Carcinogenesis Trial in Tainan (probiotic)

    Recruiting
    • H. Pylori Infection
    • Carcinogenesis
    • probiotic
    • Tainan, Taiwan
      National Cheng Kung University & Hospital
    Sep 15, 2022

    Multiple Sclerosis Trial in Rennes (Blood sampling, CSF sampling)

    Recruiting
    • Multiple Sclerosis
    • Blood sampling
    • CSF sampling
    • Rennes, France
      CHU Rennes
    Apr 26, 2022

    Cologne Placenta Cohort (CPC)

    Active, not recruiting
    • Obesity, Maternal
    • Gestational Diabetes Mellitus in Pregnancy
    • no intervention
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Jun 17, 2022

    Colorectal Carcinoma (CRC), Endometrial Carcinoma (EC) Trial in Oklahoma City (TPST-1495)

    Not yet recruiting
    • Colorectal Carcinoma (CRC)
    • Endometrial Carcinoma (EC)
    • Oklahoma City, Oklahoma
      Stephenson's Cancer Center
    Nov 8, 2023

    Carcinoma, Basal Cell Trial in United States (CX-4945)

    Recruiting
    • Carcinoma, Basal Cell
    • Aurora, Colorado
    • +3 more
    Mar 11, 2022

    Sun Damaged Skin Trial in Tucson (Solar Simulated Light (SSL))

    Recruiting
    • Sun Damaged Skin
    • Solar Simulated Light (SSL)
    • Tucson, Arizona
      University of Arizona
    Jun 1, 2022

    Chronic Kidney Disease (CKD), Type 2 Diabetes (T2DM), Coronary Artery Disease (CAD) Trial in Jacksonville (Clopidogrel,

    Active, not recruiting
    • Chronic Kidney Disease (CKD)
    • +2 more
    • Jacksonville, Florida
      University of Florida Jacksonville
    Aug 5, 2022

    IL13 Signaling in Allergic Asthma

    Not yet recruiting
    • Asthma, Allergic
    • +2 more
      • Durham, North Carolina
        Duke Asthma Allergy and Airway Center
      Jul 26, 2022

      Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States

      Not yet recruiting
      • Esophageal Adenocarcinoma
      • +2 more
      • Palo Alto, California
      • +5 more
      Jan 12, 2023

      Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

      Not yet recruiting
      • Metastatic Triple-Negative Breast Carcinoma
      • Breast Cancer
      • Neratinib Oral Tablet
      • Ruxolitinib Oral Tablet
      • Dallas, Texas
        Baylor University Medical Center, Baylor Charles A Sammons Cance
      Aug 22, 2023

      Dietary Protein Trial in Saint Louis (Dietary protein shake)

      Active, not recruiting
      • Dietary Protein
      • Dietary protein shake
      • Saint Louis, Missouri
        Washington University
      Jan 29, 2023

      Rheumatoid Arthritis Trial (Placebo, Nitazoxanide 500Mg Oral Tablet, Escitalopram 10mg)

      Not yet recruiting
      • Rheumatoid Arthritis
      • Placebo
      • +2 more
      • (no location specified)
      Jul 27, 2022